{
    "2019-12-19": [
        [
            {
                "time": "2018-03-15",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Johnson & Johnson",
                        "Eli Lilly",
                        "PNC Financial",
                        "EOG Resources",
                        "Archer-Daniels-Midland"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance",
                        "energy",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-01",
                "original_text": "Pfizer's Braftovi sNDA Accepted by FDA for Priority Review",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Braftovi",
                        "sNDA",
                        "FDA",
                        "Priority Review"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "Lilly Launches Campaign to Increase Awareness of Insulin Cost-Saving Options",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Insulin",
                        "Cost-Saving",
                        "Campaign"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "Eli Lilly Stock Jumps Higher After Analyst Upgrade",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock Jumps",
                        "Analyst Upgrade"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}